ArticleBioengineering & translational medicine2024

A bioengineered anti-VEGF protein with high affinity and high concentration for intravitreal treatment of wet age-related macular degeneration.

Chengnan Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.